TEL AVIV

Medigus Announces Corporate Rebranding Changes Name to Xylo Technologies Ltd. to Reflect Core Values of its Business

Retrieved on: 
Tuesday, April 9, 2024
MDGS, XYLO, Heart

Tel Aviv, Israel, April 09, 2024 (GLOBE NEWSWIRE) -- Medigus Ltd. (NASDAQ: MDGS) (“Medigus” or the “Company”), a technology-based company engaged in advanced innovative technologies, announced today a corporate rebranding to reflect current focus in innovation technologies. At the heart of this rebranding is a change of the Company’s name to Xylo Technologies Ltd. to embody its corporate vision and core values.

Key Points: 
  • Medigus’ Nasdaq trading symbol will change to XYLO on April 18, 2024
    Tel Aviv, Israel, April 09, 2024 (GLOBE NEWSWIRE) -- Medigus Ltd. (NASDAQ: MDGS) (“Medigus” or the “Company”), a technology-based company engaged in advanced innovative technologies, announced today a corporate rebranding to reflect current focus in innovation technologies.
  • At the heart of this rebranding is a change of the Company’s name to Xylo Technologies Ltd. to embody its corporate vision and core values.
  • The rebranding includes a new name and an update to the Company’s corporate logo, as well as a new website.
  • In addition, the Company’s Nasdaq trading symbols will change to XYLO.

OTORIO Announces Integration with ServiceNow to Enhance Operational Cybersecurity and Efficiency

Retrieved on: 
Tuesday, April 9, 2024
Organization, Risk management, ServiceNow, Communication, Environment, CMDB, Internet of things, Risk, OT

OTORIO's direct integration with the Now Platform gives ServiceNow customers a unified solution to maximize operational security and efficiency and proactively protect OT assets and operations.

Key Points: 
  • OTORIO's direct integration with the Now Platform gives ServiceNow customers a unified solution to maximize operational security and efficiency and proactively protect OT assets and operations.
  • Continuous asset oversight provides ServiceNow full visibility into the customers’ ecosystem so they can strategically manage critical risk with automated ticketing and incident resolution tailored to ensure OT security in interconnected operational environments.
  • "This integration marks a significant milestone in our mission to secure critical infrastructure and industrial machines across industries," said Daniel Bren, CEO and co-founder at OTORIO.
  • "Combining our advanced technologies with ServiceNow's comprehensive platform enables industrial organizations to effectively monitor and mitigate risks, enhance their OT cybersecurity resilience, and achieve their digital objectives."

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Fair Isaac Corporation - FICO

Retrieved on: 
Monday, April 8, 2024
Letter, FICO, Justice, Pomerantz

NEW YORK, April 08, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Fair Isaac Corporation (“FICO” or the “Company”) (NYSE: FICO).

Key Points: 
  • NEW YORK, April 08, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Fair Isaac Corporation (“FICO” or the “Company”) (NYSE: FICO).
  • The investigation concerns whether FICO and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.
  • Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions.
  • The Firm has recovered billions of dollars in damages awards on behalf of class members.

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of PSQ Holdings, Inc. - PSQH

Retrieved on: 
Monday, April 8, 2024
Classification, News, LLP, WalletHub, Security (finance), Business analyst, Bank statement, ASC, Pomerantz, PSQ

NEW YORK, April 08, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of PSQ Holdings, Inc. (“PSQ” or the “Company”) (NYSE: PSQH).

Key Points: 
  • NEW YORK, April 08, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of PSQ Holdings, Inc. (“PSQ” or the “Company”) (NYSE: PSQH).
  • The investigation concerns whether PSQ and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.
  • Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions.
  • The Firm has recovered billions of dollars in damages awards on behalf of class members.

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of The Bancorp, Inc. - TBBK

Retrieved on: 
Monday, April 8, 2024
REBL, Bank holding company, News, LLP, Pomerantz

NEW YORK, April 08, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of The Bancorp, Inc. (“TBBK” or the “Company”) (NASDAQ: TBBK).

Key Points: 
  • NEW YORK, April 08, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of The Bancorp, Inc. (“TBBK” or the “Company”) (NASDAQ: TBBK).
  • Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.
  • The investigation concerns whether TBBK and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.
  • Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions.

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Bristol-Myers Squibb Company - BMY

Retrieved on: 
Monday, April 8, 2024
BMY, Bristol Myers Squibb, News, LLP, Death, Pomerantz, Food

NEW YORK, April 08, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Bristol-Myers Squibb Company (“Bristol Myers” or the “Company”) (NYSE: BMY).

Key Points: 
  • NEW YORK, April 08, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Bristol-Myers Squibb Company (“Bristol Myers” or the “Company”) (NYSE: BMY).
  • Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.
  • Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions.
  • The Firm has recovered billions of dollars in damages awards on behalf of class members.

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Sonder Holdings Inc. - SOND

Retrieved on: 
Monday, April 8, 2024
Sonder, News, LLP, Bank statement, Pomerantz

NEW YORK, April 08, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Sonder Holdings Inc. (“Sonder” or the “Company”) (NASDAQ: SOND).

Key Points: 
  • NEW YORK, April 08, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Sonder Holdings Inc. (“Sonder” or the “Company”) (NASDAQ: SOND).
  • The investigation concerns whether Sonder and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.
  • Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions.
  • The Firm has recovered billions of dollars in damages awards on behalf of class members.

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Spruce Biosciences, Inc. - SPRB

Retrieved on: 
Monday, April 8, 2024
Congenital adrenal hyperplasia, Prior, News, LLP, Spruce, CAH, Hyperandrogenism, Pomerantz

NEW YORK, April 08, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Spruce Biosciences, Inc.  (“Spruce” or the “Company”) (NASDAQ: SPRB).

Key Points: 
  • NEW YORK, April 08, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Spruce Biosciences, Inc.  (“Spruce” or the “Company”) (NASDAQ: SPRB).
  • The investigation concerns whether Spruce and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.
  • Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions.
  • The Firm has recovered billions of dollars in damages awards on behalf of class members.

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Enfusion, Inc. - ENFN

Retrieved on: 
Monday, April 8, 2024
Software as a service, CFO, Risk, News, LLP, Pomerantz, CSO

NEW YORK, April 08, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Enfusion, Inc. (“Enfusion” or the “Company”) (NYSE: ENFN).

Key Points: 
  • NEW YORK, April 08, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Enfusion, Inc. (“Enfusion” or the “Company”) (NYSE: ENFN).
  • The investigation concerns whether Enfusion and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.
  • Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions.
  • The Firm has recovered billions of dollars in damages awards on behalf of class members.

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Lifecore Biomedical, Inc. - LFCR

Retrieved on: 
Monday, April 8, 2024
Financial statement, Prior, News, LLP, Bank statement, Annual report, Pomerantz

NEW YORK, April 08, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Lifecore Biomedical, Inc. (“Lifecore” or the “Company”) (NASDAQ: LFCR).

Key Points: 
  • NEW YORK, April 08, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Lifecore Biomedical, Inc. (“Lifecore” or the “Company”) (NASDAQ: LFCR).
  • The investigation concerns whether Lifecore and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.
  • Further, the 2023 10-K stated that “this determination resulted from the identification of errors in the Prior Financial Statements related to adjustments [.
  • Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions.